One of the most powerful tradable market events is a short squeeze, so traders are always on the lookout for the next short squeeze candidate. S3 Partners analyst Ihor Dusaniwsky has just released a list of potential short squeeze stocks based on S3’s proprietary Squeeze Score rating
The Squeeze Score incorporates S3’s Crowded Score, a measure of a stock’s total, short percent of float, stock loan liquidity, and trading liquidity.
Dusaniwsky says a stock can be “crowded” with short selling and still not be a good short squeeze candidate unless short sellers have endured substantial losses and are being forced to exit the position. S3’s Squeeze Score also incorporates a stock’s days-to-cover and short seller losses over the past 30 days and seven days.
“Having a high Squeeze Score does not guarantee that a stock will be squeezed—but it does highlight stocks that have a much higher squeeze potential than most other stocks in the market,” Dusaniwsky said.
Short Squeeze Candidates
Here’s a look at the 12 stocks that have the highest Squeeze Score and post potential for a short squeeze, according to S3 Partners. Total short interest is included for each stock:- Faraday Future Intelligent Electric Inc., $118.6 million.
- Canoo Inc., $132.5 million.
- Gossamer Bio Inc., $133.3 million.
- Verve Therapeutics Inc., $224 million.
- Lightwave Logic, Inc., $176.6 million.
- Beam Therapeutics Inc., $799.3 million.
- Cowen Inc., $185.2 million.
- Veru Inc., $185.2 million.
- Beyond Meat Inc., $843.9 million.
- Fate Therapeutics Inc., $696.1 million.
- Allogene Therapeutics Inc., $265.6 million.
- SpringWorks Therapeutics Inc., $353.5 million.
